Walleye Capital
OKUR

Walleye Capital’s OnKure Therapeutics OKUR Stock Holding History

Walleye Capital’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Buy
+71,103
New +$305K ﹤0.01% 3104
2025
Q1 		– Sell
-13,495
Closed -$116K – 5305
2024
Q4 		$116K Buy
+13,495
New +$204K ﹤0.01% 4061
2023
Q3 		– Sell
-4,955
Closed -$325K – 5403
2023
Q2 		$325K Buy
+4,955
New +$399K ﹤0.01% 2726

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Walleye Capital's OKUR Position: Q2 2026 in Review

Walleye Capital opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 71,103 shares worth $324K. The stake represents ﹤0.01% of the portfolio and ranks #3104 among its holdings. This is a return to the name: Walleye Capital previously reported a position in OKUR as recently as Q4 2024.

Walleye Capital first reported a position in OKUR in Q2 2023 and has held it in 3 quarters since. The position peaked at $325K in Q2 2023. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Walleye Capital held 71,103 shares of OnKure Therapeutics worth $324K as of Q2 2026.
  • OnKure Therapeutics was a new Walleye Capital position in Q2 2026.
  • OnKure Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3104 holding.
  • Walleye Capital first reported a position in OnKure Therapeutics in Q2 2023 and has held it in 3 quarters since.
  • Walleye Capital's OnKure Therapeutics position peaked at $325K in Q2 2023.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.